Active Shortage Injection Anesthesia
Dexmedetomidine Hydrochlorid · 1,980 days since initial FDA posting
Brand: DEXMEDETOMIDINE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Meitheal Pharmaceuticals, Inc.).
Availability on file: Available
Dexmedetomidine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Meitheal Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)
- Package NDC
- 71288-505-03
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 10, 2021
- Last Updated
- Aug 19, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
HQ Specialty Pharma
Injection